1) Statistics Korea. Causes of Death Statistics in 2020. 2021.
2) Ryu S, Nam HJ, Jhon M, Lee JY, Kim JM, Kim SW. Trends in suicide deaths before and after the COVID-19 outbreak in Korea. PLOS One (under review).
4) Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005;62:593-602.
5) Patel V, Flisher AJ, Hetrick S, McGorry P. Mental health of young people: a global public-health challenge. Lancet 2007;369:1302-1313.
6) Gore FM, Bloem PJ, Patton GC, Ferguson J, Joseph V, Coffey C, et al. Global burden of disease in young people aged 10-24 years: a systematic analysis. Lancet 2011;377:2093-2102.
7) Insel TR. Assessing the economic costs of serious mental illness. Am J Psychiatry 2008;165:663-665.
9) Brewer WJ, Lambert TJ, Witt K, Dileo J, Duff C, Crlenjak C, et al. Intensive case management for high-risk patients with first-episode psychosis: service model and outcomes. Lancet Psychiatry 2015;2:29-37.
10) Kim SW. Psychosocial intervention for patients with schizophrenia. J Korean Neuropsychiatr Assoc 2018;57:235-243.
12) Birchwood M, Connor C, Lester H, Patterson P, Freemantle N, Marshall M, et al. Reducing duration of untreated psychosis: care pathways to early intervention in psychosis services. Br J Psychiatry 2013;203:58-64.
13) National Institute for Clinical Excellence. Implementing the early intervention in psychosis access and waiting time standard: Guidance. London: NHS England Publications; 2016.
14) Kane JM, Robinson DG, Schooler NR, Mueser KT, Penn DL, Rosenheck RA, et al. Comprehensive versus usual Community Care for First-Episode Psychosis: 2-year outcomes from the NIMH RAISE early treatment program. Am J Psychiatry 2016;173:362-372.
19) Amminger GP, Schäfer MR, Papageorgiou K, Klier CM, Cotton SM, Harrigan SM, et al. Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial. Arch Gen Psychiatry 2010;67:146-154.
20) Polari A, Lavoie S, Sarrasin P, Pellanda V, Cotton S, Conus P. Duration of untreated psychosis: a proposition regarding treatment definition. Early Interv Psychiatry 2011;5:301-308.
21) Murru A, Carpiniello B. Duration of untreated illness as a key to early intervention in schizophrenia: a review. Neurosci Lett 2018;669:59-67.
23) Jo A, Kim H, Lee JY, Kim JM, Jeong MH, Chung YC, et al. The effects of patient personality traits and family cohesion on the treatment delay for patients with first-episode schizophrenia spectrum disorder. Early Interv Psychiatry 2021;15:889-895.
24) Birchwood M, Todd P, Jackson C. Early intervention in psychosis. The critical period hypothesis. Br J Psychiatry Suppl 1998;172:53-59.
25) McGorry PD. The recognition and optimal management of early psychosis: an evidence-based reform. World Psychiatry 2002;1:76-83.
26) Lee GY, Yu HY, Jhon M, Yoon JS, Kim SW. Intensive cognitive behavioral case management for functional recovery of young patients with schizophrenia. Korean J Schizophr Res 2016;19:32-37.
27) Kim SW, Kim JK, Jhon M, Lee HJ, Kim H, Kim JW, et al. Mindlink: a stigma-free youth-friendly community-based early intervention centre in Korea. Early Interv Psychiatry 2021;15:1389-1394.
28) Álvarez-Jiménez M, Gleeson JF, Henry LP, Harrigan SM, Harris MG, Killackey E, et al. Road to full recovery: longitudinal relationship between symptomatic remission and psychosocial recovery in first-episode psychosis over 7.5 years. Psychol Med 2012;42:595-606.
29) Marder SR. Integrating pharmacological and psychosocial treatments for schizophrenia. Acta Psychiatr Scand Suppl 2000;407:87-90.
31) Kim SW, Lee GY, Yu HY, Jung EI, Lee JY, Kim SY, et al. Development and feasibility of smartphone application for cognitive-behavioural case management of individuals with early psychosis. Early Interv Psychiatry 2018;12:1087-1093.
33) Jhon M, Wang SY, Kim SY, Lee JY, Kim JM, Shin IS, et al. Roles of Psychiatrists in Mental Health Services: The Gwangju Mental Health Project “Mind Doctor”. J Korean Neuropsychiatr Assoc 2021;60:70-77.
35) Vázquez-Bourgon J, Ibáñez Alario M, Mayoral-van Son J, Gómez Revuelta M, Ayesa Arriola R, Juncal Ruiz M, et al. A 3-year prospective study on the metabolic effect of aripiprazole, quetiapine and ziprasidone: A pragmatic clinical trial in first episode psychosis patients. Eur Neuropsychopharmacol 2020;39:46-55.
36) Kinoshita Y, Furukawa TA, Kinoshita K, Honyashiki M, Omori IM, Marshall M, et al. Supported employment for adults with severe mental illness. Cochrane Database Syst Rev 2013;9:CD008297.